The State
Institute for Drug Control (the Institute) received an application from the
General Health Insurance Company of the Czech Republic (VZP) for a change in
the amount and conditions of reimbursement from public health insurance for
selected orphan medicinal products, based on the following statutory provision:
“In the
event of a significant change in the price references of an...
Are you interested in reading regular commentaries on decisions by Pharmeca a.s.? Feel free to contact us.
At Pharmeca, we help you navigate the complex landscape of pharmaceutical and medical device information. We also offer flexible services that can be tailored to your needs at any time.
Our market position and experience allow us to support you whenever you need expert guidance.
Our knowledge, your opportunity.
